UK markets closed
  • FTSE 100

    7,122.32
    -6.89 (-0.10%)
     
  • FTSE 250

    22,646.08
    -38.76 (-0.17%)
     
  • AIM

    1,182.30
    -6.44 (-0.54%)
     
  • GBP/EUR

    1.1690
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.3235
    -0.0067 (-0.50%)
     
  • BTC-GBP

    37,053.93
    -3,060.93 (-7.63%)
     
  • CMC Crypto 200

    1,367.14
    -74.62 (-5.18%)
     
  • S&P 500

    4,538.43
    -38.67 (-0.84%)
     
  • DOW

    34,580.08
    -59.71 (-0.17%)
     
  • CRUDE OIL

    66.22
    -0.28 (-0.42%)
     
  • GOLD FUTURES

    1,782.10
    +21.40 (+1.22%)
     
  • NIKKEI 225

    28,029.57
    +276.20 (+1.00%)
     
  • HANG SENG

    23,766.69
    -22.24 (-0.09%)
     
  • DAX

    15,169.98
    -93.13 (-0.61%)
     
  • CAC 40

    6,765.52
    -30.23 (-0.44%)
     

Worldwide Diagnostic Imaging Industry to 2026 - Use of Blockchain in Diagnostic Imaging Presents Opportunities

·8-min read

Dublin, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The "Diagnostic Imaging Market Research Report by Modality, End-user, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Diagnostic Imaging Market size was estimated at USD 24.89 billion in 2020, is expected to reach USD 26.30 billion in 2021, and projected to grow at a CAGR of 6.00% reaching USD 35.32 billion by 2026.

Market Statistics

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage

This research report categorizes the Diagnostic Imaging to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Modality, the market was studied across Computed Tomography, MRI Systems, Mammography Systems, Nuclear Imaging Systems, Ultrasound Imaging Systems, and X-Ray Imaging Systems. The Computed Tomography is further studied across High End Scanners (128-Slice and More), Low End Scanners (~16-Slice), and Mid Range Scanners (~64-Slice). The MRI Systems is further studied across High field MRI systems (1.5-3 T), Low and mid field MRI systems (< 1.5 T), and Very High, and Ultra High Field MRI Systems (3T and more). The Ultrasound Imaging Systems is further studied across 2D Ultrasound, 3D and 4D Ultrasound, and Doppler Ultrasound. The X-Ray Imaging Systems is further studied across Analog Systems and Digital Systems.

  • Based on End-user, the market was studied across Diagnostic Centers and Hospitals.

  • Based on Application, the market was studied across Cardiology, Gastroenterology, Gynecology, Neurology, Oncology, and Orthopedics.

  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Competitive Strategic Window

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Diagnostic Imaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Diagnostic Imaging Market, including Agfa-Gevaert N.V., Arterys Inc., Canon Inc., Caption Health, Inc., Carestream Health, CellmatiQ GmbH, CurveBeam LLC, Esaote SPA, FUJIFILM Holdings Corporation, GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Mindray Medical International Limited, Planmed Oy, Samsung Electronics Co., Ltd., Shimadzu Corporation, and Siemens Healthineers AG.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Diagnostic Imaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Diagnostic Imaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Diagnostic Imaging Market?
4. What is the competitive strategic window for opportunities in the Global Diagnostic Imaging Market?
5. What are the technology trends and regulatory frameworks in the Global Diagnostic Imaging Market?
6. What is the market share of the leading vendors in the Global Diagnostic Imaging Market?
7. What modes and strategic moves are considered suitable for entering the Global Diagnostic Imaging Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing geriatric population and the subsequent increase in the prevalence of associated diseases
5.2.2. Technological advancements in diagnostic imaging modalities coupled with the need for early diagnosis
5.2.3. Growing investments, funds, and grants by public-private organizations
5.3. Restraints
5.3.1. High cost of diagnostic imaging systems and growing regulatory burden in the U.S.
5.4. Opportunities
5.4.1. Adoption of artificial intelligence and analytics in diagnostic imaging
5.4.2. Use of blockchain in diagnostic imaging
5.4.3. Growing adoption of teleradiology and mobile solutions
5.5. Challenges
5.5.1. Increasing adoption of refurbished diagnostic imaging systems and a dearth of trained professionals

6. Diagnostic Imaging Market, by Modality
6.1. Introduction
6.2. Computed Tomography
6.2.1. High End Scanners (128-Slice and More)
6.2.2. Low End Scanners (~16-Slice)
6.2.3. Mid Range Scanners (~64-Slice)
6.3. MRI Systems
6.3.1. High field MRI systems (1.5-3 T)
6.3.2. Low and mid field MRI systems (< 1.5 T)
6.3.3. Very High, and Ultra High Field MRI Systems (3T and more)
6.4. Mammography Systems
6.5. Nuclear Imaging Systems
6.6. Ultrasound Imaging Systems
6.6.1. 2D Ultrasound
6.6.2. 3D and 4D Ultrasound
6.6.3. Doppler Ultrasound
6.7. X-Ray Imaging Systems
6.7.1. Analog Systems
6.7.2. Digital Systems

7. Diagnostic Imaging Market, by End-user
7.1. Introduction
7.2. Diagnostic Centers
7.3. Hospitals

8. Diagnostic Imaging Market, by Application
8.1. Introduction
8.2. Cardiology
8.3. Gastroenterology
8.4. Gynecology
8.5. Neurology
8.6. Oncology
8.7. Orthopedics

9. Americas Diagnostic Imaging Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Diagnostic Imaging Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Diagnostic Imaging Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Agfa-Gevaert N.V.
13.2. Arterys Inc.
13.3. Canon Inc.
13.4. Caption Health, Inc.
13.5. Carestream Health
13.6. CellmatiQ GmbH
13.7. CurveBeam LLC
13.8. Esaote SPA
13.9. FUJIFILM Holdings Corporation
13.10. GE Healthcare
13.11. Hologic, Inc.
13.12. Koninklijke Philips N.V.
13.13. Mindray Medical International Limited
13.14. Planmed Oy
13.15. Samsung Electronics Co., Ltd.
13.16. Shimadzu Corporation
13.17. Siemens Healthineers AG

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/5f17h1

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting